4//SEC Filing
Essetifin SPA 4
Accession 0001213900-18-013186
CIK 0000707511other
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 4:04 PM ET
Size
30.5 KB
Accession
0001213900-18-013186
Insider Transaction Report
Form 4
SIGMA TAU FINANZIARIA SPA
10% Owner
Transactions
- Conversion
Common Stock
2018-09-27$0.06/sh+3,133,681$188,021→ 34,989,080 total - Conversion
Convertible Promissory Note (right to buy)
2018-09-27$150000.00/sh→ 0 totalExercise: $0.06From: 2013-09-12→ Common Stock (3,133,681 underlying)
Cavazza Enrico
10% Owner
Transactions
- Conversion
Common Stock
2018-09-27$0.06/sh+3,133,681$188,021→ 34,989,080 total - Conversion
Convertible Promissory Note (right to buy)
2018-09-27$150000.00/sh→ 0 totalExercise: $0.06From: 2013-09-12→ Common Stock (3,133,681 underlying)
Cavazza Silvia
10% Owner
Transactions
- Conversion
Common Stock
2018-09-27$0.06/sh+3,133,681$188,021→ 34,989,080 total - Conversion
Convertible Promissory Note (right to buy)
2018-09-27$150000.00/sh→ 0 totalExercise: $0.06From: 2013-09-12→ Common Stock (3,133,681 underlying)
CAVAZZA PAOLO
10% Owner
Transactions
- Conversion
Common Stock
2018-09-27$0.06/sh+3,133,681$188,021→ 34,989,080 total - Conversion
Convertible Promissory Note (right to buy)
2018-09-27$150000.00/sh→ 0 totalExercise: $0.06From: 2013-09-12→ Common Stock (3,133,681 underlying)
Cavazza Preta Martina
10% Owner
Transactions
- Conversion
Convertible Promissory Note (right to buy)
2018-09-27$150000.00/sh→ 0 totalExercise: $0.06From: 2013-09-12→ Common Stock (3,133,681 underlying) - Conversion
Common Stock
2018-09-27$0.06/sh+3,133,681$188,021→ 34,989,080 total
Cavazza Francesca
10% Owner
Transactions
- Conversion
Common Stock
2018-09-27$0.06/sh+3,133,681$188,021→ 34,989,080 total - Conversion
Convertible Promissory Note (right to buy)
2018-09-27$150000.00/sh→ 0 totalExercise: $0.06From: 2013-09-12→ Common Stock (3,133,681 underlying)
Footnotes (2)
- [F1]On September 27, 2018, Essetifin S.p.A., an Italian corporation ("Essetifin"), exercised its option to convert the Convertible Promissory Note, originally issued on September 11, 2013 and reissued on March 13, 2018, in an initial principal amount of $150,000 (the "Note"), including all accrued but unpaid interest thereon, into shares of common stock, $0.001 par value per share (the "Common Stock"), of RegeneRx Biopharmaceuticals, Inc. (the "Company"). The Company issued a total of 3,133,681 shares of Common Stock to Essetifin upon conversion of the Note, including 633,681 shares of Common Stock issued in respect of the accrued but unpaid interest on the Note. As a result of the conversion and as of September 27, 2018, Essetifin directly owns 34,989,080 shares of Common Stock, which includes 3,133,681 shares of Common Stock that were issued upon conversion the Note.
- [F2]Dispositive power over the shares of Common Stock owned by Essetifin is shared by Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza. Each of Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza disclaims beneficial ownership of all shares of Common Stock held by Essetifin except to the extent of any pecuniary interest therein.
Issuer
REGENERX BIOPHARMACEUTICALS INC
CIK 0000707511
Entity typeother
Related Parties
1- filerCIK 0001092601
Filing Metadata
- Form type
- 4
- Filed
- Sep 27, 8:00 PM ET
- Accepted
- Sep 28, 4:04 PM ET
- Size
- 30.5 KB